Literature DB >> 15534604

Mechanisms of axon-glial injury of the optic nerve.

A Compston1.   

Abstract

The central concept underlying ideas on the pathogenesis of multiple sclerosis is that inflammatory events cause acute injury of axons and myclin. The phases of symptom onset, recovery, persistence, and progression in multiple sclerosis can be summarized as functional impairment with intact structure due to direct effects of inflammatory mediators; demyelination and axonal injury with recovery through plasticity and remyelination; and chronic axonal loss due to failure of enduring remyelination from loss of trophic support for axons normally provided by cells of the oligodendrocyte lineage. Cell death may occur in response to a state of injury from which protection would be anticipated under more favourable neurobiological conditions. Conversely, optimal growth factor environment may save cells from otherwise lethal events occurring at the cell membrane. Hence, in the context of brain inflammation, there is an inseparable interplay between immunological and neurobiological contributions to tissue injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15534604     DOI: 10.1038/sj.eye.6701561

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  3 in total

1.  VEP and PERG in patients with multiple sclerosis, with and without a history of optic neuritis.

Authors:  M Janáky; Á Jánossy; G Horváth; G Benedek; G Braunitzer
Journal:  Doc Ophthalmol       Date:  2017-04-18       Impact factor: 2.379

2.  Diffusion tensor imaging detected optic nerve injury correlates with decreased compound action potentials after murine retinal ischemia.

Authors:  Qing Wang; Roman Vlkolinsky; Mingqiang Xie; Andre Obenaus; Sheng-Kwei Song
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-17       Impact factor: 4.799

3.  Visual field defects in acute optic neuritis--distribution of different types of defect pattern, assessed with threshold-related supraliminal perimetry, ensuring high spatial resolution.

Authors:  J Nevalainen; E Krapp; J Paetzold; I Mildenberger; D Besch; R Vonthein; J L Keltner; C A Johnson; U Schiefer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-02-01       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.